Literature DB >> 29352692

CKD-EPI versus Cockcroft-Gault formula for predicting contrast-induced nephropathy following percutaneous coronary intervention in patients without significant renal impairment.

Mário B G Nunes1, Antônio C Filho2, Valéria R C Alvares3, Rafael Meneguz-Moreno2, Edgar Lamas2, Vitor Loures2, Daniel Chamié2, Alexandre Abizaid2.   

Abstract

INTRODUCTION: Individuals with glomerular filtration rate (GFR) ≥60 ml/min/1.73 m2 estimated by the Cockcroft-Gault formula (CG) who undergo percutaneous coronary intervention (PCI) frequently develop contrast-induced nephropathy (CIN). This study aimed to assess whether individuals with significant renal impairment assessed by the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) formula, but not by CG, more often develop CIN following PCI than those without renal impairment by either formula.
METHODS: In this cross-sectional study analyzing patients with baseline CG GFR ≥60 ml/min/1.73 m2 before PCI, subjects were divided into two groups according to CIN occurrence. Baseline CKD-EPI GFR was calculated for all patients.
RESULTS: We analyzed 140 patients. Baseline GFR was 87.5±21.3 and 77.1±15.0 ml/min/1.73 m2 for CG and CKD-EPI, respectively. CIN occurred in 84.6% of individuals with baseline CKD-EPI GFR <60 ml/min/1.73 m2 vs. 51.1% of those without. Males and those with higher body mass index were more likely to present baseline CKD-EPI GFR <60 ml/min/1.73 m2 (p=0.021). Non-ionic contrast agent use and baseline CKD-EPI GFR ≥60 ml/min/1.73 m2 were protective factors against CIN. Greater amounts of contrast agent and acute coronary syndrome were associated with higher CIN risk. In subjects with serum creatinine <1.0 mg/dl, GFR was more likely to be overestimated by CG, but not by CKD-EPI (sensitivity 100.0%; specificity 52.0%).
CONCLUSION: In patients undergoing PCI without renal dysfunction by CG, a finding of CKD-EPI GFR <60 ml/ min/1.73 m2 was associated with a higher probability of CIN, especially among men and those with higher body mass index.
Copyright © 2017 Sociedade Portuguesa de Cardiologia. Publicado por Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Contrast media; Glomerular filtration rate; Intervenção coronária percutânea; Meios de contraste; Percutaneous coronary intervention; Taxa de filtração glomerular

Mesh:

Substances:

Year:  2018        PMID: 29352692     DOI: 10.1016/j.repc.2017.05.009

Source DB:  PubMed          Journal:  Rev Port Cardiol (Engl Ed)        ISSN: 2174-2049


  2 in total

1.  C/MIC &gt; 4: A Potential Instrument to Predict the Efficacy of Meropenem.

Authors:  Yichang Zhao; Chenlin Xiao; Jingjing Hou; Jiamin Wu; Yiwen Xiao; Bikui Zhang; Indy Sandaradura; Hong Luo; Jinhua Li; Miao Yan
Journal:  Antibiotics (Basel)       Date:  2022-05-16

2.  Does Prolonged Infusion Time Really Improve the Efficacy of Meropenem Therapy? A Prospective Study in Critically Ill Patients.

Authors:  Yi-Chang Zhao; Yang Zou; Yi-Wen Xiao; Feng Wang; Bi-Kui Zhang; Da-Xiong Xiang; Feng Yu; Hong Luo; Indy Sandaradura; Miao Yan
Journal:  Infect Dis Ther       Date:  2021-11-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.